CARE Ratings Issues Q2FY27 Monitoring Report for Jindal Supreme IPO Proceeds
Jindal Supreme (India) Ltd 路 Others (Uncategorized) 路 14 Nov 2026, 8:51 pm
CARE Ratings Issues Q2FY27 Monitoring Report for Jindal Supreme IPO Proceeds Jindal Supreme (India) Limited utilized Rs 61.42 crore of its Rs 99.89 crore IPO proceeds during Q2FY27 with no material deviations reported by CARE Ratings. Deployments included Rs 56.87 crore for debt repayment (HDFC Bank and Kotak Mahindra Bank) and Rs 4.55 crore for raw material procurement under general corporate purposes. An inadvertent Rs 0.60 crore transfer was reversed on 7th Oct'26. Unutilized proceeds of Rs 38.47 crore remain in bank accounts. CARE noted frequent Key Managerial Personnel changes over the last two years.
Original exchange filing (PDF)
More announcements from Jindal Supreme (India) Ltd
- Jindal Supreme (India)Limied has informed the Exchange about Link of Audio Recording of the call 路 18 Nov 2026
- Jindal Supreme (india) has submitted Investor presentation to the stock exchange. 路 16 Nov 2026
- Un-Audited Standalone Financial Results of the Company for the Quarter and Half year endined on September 30, 2026, together with the Limited Review Report thereon, as issued by statutory .... 路 14 Nov 2026
- Jindal Supreme (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Outcome of the Board Meeting held on November 14, 2026, inter alia, approving the Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026, along with .... 路 14 Nov 2026
- Jindal Supreme (India) Limited has informed the Stock Exchange(s) regarding the schedule of an Investor Meeting to be held on November 17, 2026, at 02:00 P.M. 路 17 Nov 2026
- JINDAL SUPREME(INDIA)LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
